BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28842746)

  • 1. Expression profiling and immunolocalization of Na
    Madunić IV; Breljak D; Karaica D; Koepsell H; Sabolić I
    Pflugers Arch; 2017 Dec; 469(12):1545-1565. PubMed ID: 28842746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody.
    Balen D; Ljubojevic M; Breljak D; Brzica H; Zlender V; Koepsell H; Sabolic I
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C475-89. PubMed ID: 18524944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.
    Vrhovac I; Balen Eror D; Klessen D; Burger C; Breljak D; Kraus O; Radović N; Jadrijević S; Aleksic I; Walles T; Sauvant C; Sabolić I; Koepsell H
    Pflugers Arch; 2015 Sep; 467(9):1881-98. PubMed ID: 25304002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat renal glucose transporter SGLT1 exhibits zonal distribution and androgen-dependent gender differences.
    Sabolić I; Skarica M; Gorboulev V; Ljubojević M; Balen D; Herak-Kramberger CM; Koepsell H
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F913-26. PubMed ID: 16204409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
    Powell DR; Smith M; Greer J; Harris A; Zhao S; DaCosta C; Mseeh F; Shadoan MK; Sands A; Zambrowicz B; Ding ZM
    J Pharmacol Exp Ther; 2013 May; 345(2):250-9. PubMed ID: 23487174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans.
    Ferté L; Marino A; Battault S; Bultot L; Van Steenbergen A; Bol A; Cumps J; Ginion A; Koepsell H; Dumoutier L; Hue L; Horman S; Bertrand L; Beauloye C
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H838-H853. PubMed ID: 33416451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21 improves glucose homeostasis partially via down-regulation of Na
    Wang N; Li S; Guo XC; Li JY; Ren GP; Li DS
    Biomed Pharmacother; 2019 Jan; 109():1070-1077. PubMed ID: 30551357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RS1 (Rsc1A1) deficiency limits cerebral SGLT1 expression and delays brain damage after experimental traumatic brain injury.
    Sebastiani A; Greve F; Gölz C; Förster CY; Koepsell H; Thal SC
    J Neurochem; 2018 Oct; 147(2):190-203. PubMed ID: 30022488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
    Gorboulev V; Schürmann A; Vallon V; Kipp H; Jaschke A; Klessen D; Friedrich A; Scherneck S; Rieg T; Cunard R; Veyhl-Wichmann M; Srinivasan A; Balen D; Breljak D; Rexhepaj R; Parker HE; Gribble FM; Reimann F; Lang F; Wiese S; Sabolic I; Sendtner M; Koepsell H
    Diabetes; 2012 Jan; 61(1):187-96. PubMed ID: 22124465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
    Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes.
    Jurowich CF; Rikkala PR; Thalheimer A; Wichelmann C; Seyfried F; Sander V; Kreissl M; Germer CT; Koepsell H; Otto C
    Ann Surg; 2013 Jul; 258(1):89-97. PubMed ID: 23478528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure.
    Sayour AA; Oláh A; Ruppert M; Barta BA; Horváth EM; Benke K; Pólos M; Hartyánszky I; Merkely B; Radovits T
    Cardiovasc Diabetol; 2020 Sep; 19(1):159. PubMed ID: 32998746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of oligopeptide transporter PEPT1 and sodium/glucose cotransporter SGLT1 in intestinal absorption of their substrates using small GTP-binding protein Rab8-null mice.
    Kato Y; Sugiura T; Nakadera Y; Sugiura M; Kubo Y; Sato T; Harada A; Tsuji A
    Drug Metab Dispos; 2009 Mar; 37(3):602-7. PubMed ID: 19074526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycemic control in mice lacking Sglt1 and Sglt2.
    Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gut microbial metabolite of ginsenosides, compound K, induces intestinal glucose absorption and Na(+) /glucose cotransporter 1 gene expression through activation of cAMP response element binding protein.
    Wang CW; Huang YC; Chan FN; Su SC; Kuo YH; Huang SF; Hung MW; Lin HC; Chang WL; Chang TC
    Mol Nutr Food Res; 2015 Apr; 59(4):670-84. PubMed ID: 25600494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An essential role of cAMP response element-binding protein in epidermal growth factor-mediated induction of sodium/glucose cotransporter 1 gene expression and intestinal glucose uptake.
    Wang CW; Chang WL; Huang YC; Chou FC; Chan FN; Su SC; Huang SF; Ko HH; Ko YL; Lin HC; Chang TC
    Int J Biochem Cell Biol; 2015 Jul; 64():239-51. PubMed ID: 25936754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Essential Role of cAMP Response Element Binding Protein in Ginsenoside Rg1-Mediated Inhibition of Na+/Glucose Cotransporter 1 Gene Expression.
    Wang CW; Su SC; Huang SF; Huang YC; Chan FN; Kuo YH; Hung MW; Lin HC; Chang WL; Chang TC
    Mol Pharmacol; 2015 Dec; 88(6):1072-83. PubMed ID: 26429938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier.
    Elfeber K; Köhler A; Lutzenburg M; Osswald C; Galla HJ; Witte OW; Koepsell H
    Histochem Cell Biol; 2004 Mar; 121(3):201-7. PubMed ID: 14986005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of RS1 (RSC1A1) Steers Inhibition of Different Exocytotic Pathways for Glucose Transporter SGLT1 and Nucleoside Transporter CNT1, and an RS1-Derived Peptide Inhibits Glucose Absorption.
    Veyhl-Wichmann M; Friedrich A; Vernaleken A; Singh S; Kipp H; Gorboulev V; Keller T; Chintalapati C; Pipkorn R; Pastor-Anglada M; Groll J; Koepsell H
    Mol Pharmacol; 2016 Jan; 89(1):118-32. PubMed ID: 26464324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadmium decreases SGLT1 messenger RNA in mouse kidney cells.
    Blumenthal SS; Ren L; Lewand DL; Krezoski SK; Petering DH
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):49-54. PubMed ID: 9512726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.